Published on 12 May 2022
Description:
PME: Behaviour change – a need for fresh thinking and clearer understanding; The importance of a resilient clinical development strategy; Comms excellence
Categories:
Pharmaceutical Market Europe28 articles from this collection:
PME April 2022
2 - T40
3 - Comment
4 - T40
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Secret Signals
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - Will that be cash or charge?
The technology responses to this pandemic have fallen far short of expectations
14 - MIKE DIXON - Walking in their shoes
15 - PHARMA MARKETERS’ BLOG - Asking better questions to inform a stronger strategy
16-17 - CLINICAL TRIALS - Building a resilient clinical development strategy – when local events have a global impact
18 - TL MERCK - Making the case for embedding personalised healthcare in secondary care – what can pharma do to help?
19 - TL OLOGY - Realising the potential of omnichannel in medical communications
20-21 - TL HANOVER - Accelerating therapeutic discovery and development
22-31 - TRENDS - Communications excellence
32-34 - BEHAVIOUR CHANGE - a maze of decisions influenced by personal habits, experiences and intentions
35 - TL LUCID - Designing behaviour change with intelligence
36 - TL MHP - How COVID-19 has renewed the focus on behaviour change
37 - PMGROUP
38-39 - SANOFI CHINA - Building a magnet for talent
40-41 - Alzheimer’s disease: the challenges facing new drug treatments like Aduhelm
42-44 - Appointments
45 - HEALTHCARE COMMS
46 - Q&A - Matt de Gruchy
47 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
48 - Research Partnership
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services